Delcath Systems (DCTH)
(Delayed Data from NSDQ)
$7.64 USD
-0.09 (-1.16%)
Updated Jun 18, 2024 03:59 PM ET
After-Market: $7.64 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth F Momentum F VGM
Brokerage Reports
Delcath Systems, Inc. [DCTH]
Reports for Purchase
Showing records 61 - 80 ( 150 total )
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
Dropping Coverage Due to Analyst Departure
Provider: WEDBUSH SECURITIES INC.
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
The Week Ahead in Life Sciences - Upcoming Events for the Week of Sept. 9
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
The Week Ahead in Life Sciences - Upcoming Events for the Week of July 22
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
We are dropping coverage due to the realignment of the Med Tech research team.
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
The Week Ahead in Life Sciences - Upcoming Events for the Week of July 1
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
The Week Ahead in Life Sciences - Upcoming Events for the Week of June 24
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
Outlook Still Cloudy with FDA Uncertainty, Slow European Traction
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
Q1:13 EPS, Pathway to US Approval Remains Uncertain, Suspending Price Target, Reiterate NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
LIFE SCIENCES-The Week Ahead in Life Sciences - Upcoming Events for the Week of May 6
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
Downgrading to Sell on Unanimous Negative Panel Vote
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
Downgrading to NEUTRAL from OUTPERFORM -- Removing US Sales Expectations Following Negative ODAC Vote; PT to $1.30
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
FDA Briefing Documents Published; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
The Week Ahead in Life Sciences - Upcoming Events for the Week of April 29
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
PDUFA Date Extension, Restructuring and Improvement to the Balance Sheet; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G